These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37893020)

  • 1. Fetal
    Schimanski B; Kräuchi R; Stettler J; Lejon Crottet S; Niederhauser C; Clausen FB; Fontana S; Hodel M; Amylidi-Mohr S; Raio L; Abbal C; Henny C
    Biomedicines; 2023 Sep; 11(10):. PubMed ID: 37893020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of fetal RHD type in plasma of RhD negative pregnant women.
    Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA
    Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine noninvasive prenatal screening for fetal Rh D in maternal plasma-A 2-year experience from a single center in Belgium.
    Blomme S; Nollet F; Rosseel W; Bogaard N; Devos H; Emmerechts J; Cauwelier B
    Transfusion; 2022 May; 62(5):1103-1109. PubMed ID: 35352833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal screening service for fetal RHD genotyping to guide prophylaxis: the two-year experience of the Friuli Venezia Giulia region in Italy.
    Londero D; Merluzzi S; Dreossi C; Barillari G
    Blood Transfus; 2023 Mar; 21(2):93-99. PubMed ID: 35848630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive Prenatal Diagnosis of Fetal RHD Status Using Cell-free Fetal DNA in Maternal Plasma.
    Ahmadi MH; Pourfathollah AA; Rabiee M; Amirizadeh N
    J Reprod Infertil; 2022; 23(2):128-134. PubMed ID: 36043134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new biosensor for noninvasive determination of fetal RHD status in maternal blood of RhD negative pregnant women.
    Dündar Yenilmez E; Kökbaş U; Kartlaşmış K; Kayrın L; Tuli A
    PLoS One; 2018; 13(6):e0197855. PubMed ID: 29874251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal RHD Genotyping from Circulating Cell-Free Fetal DNA in Plasma of Rh Negative Pregnant Women in Iran.
    Ahmadi MH; Hantuoshzadeh S; Okhovat MA; Nasiri N; Azarkeivan A; Amirizadeh N
    Indian J Hematol Blood Transfus; 2016 Dec; 32(4):447-453. PubMed ID: 27812255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal RHD Genotyping Using Real-Time Polymerase Chain Reaction Analysis of Cell-Free Fetal DNA in Pregnancy of RhD Negative Women in South of Iran.
    Moezzi L; Keshavarz Z; Ranjbaran R; Aboualizadeh F; Behzad-Behbahani A; Abdullahi M; Ramezani A; Samsami A; Sharifzadeh S
    Int J Fertil Steril; 2016; 10(1):62-70. PubMed ID: 27123202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine noninvasive prenatal screening for fetal RHD in plasma of RhD-negative pregnant women-2 years of screening experience from Denmark.
    Clausen FB; Steffensen R; Christiansen M; Rudby M; Jakobsen MA; Jakobsen TR; Krog GR; Madsen RD; Nielsen KR; Rieneck K; Sprogøe U; Homburg KM; Baech J; Dziegiel MH; Grunnet N
    Prenat Diagn; 2014 Oct; 34(10):1000-5. PubMed ID: 24860987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice.
    Kent J; Farrell AM; Soothill P
    BMC Pregnancy Childbirth; 2014 Feb; 14():87. PubMed ID: 24568571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive fetal RhD genotyping.
    Clausen FB; Damkjær MB; Dziegiel MH
    Transfus Apher Sci; 2014 Apr; 50(2):154-62. PubMed ID: 24642067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive fetal RHD genotyping in the first trimester of pregnancy.
    Cardo L; García BP; Alvarez FV
    Clin Chem Lab Med; 2010 Aug; 48(8):1121-6. PubMed ID: 20482298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis.
    Clausen FB; Christiansen M; Steffensen R; Jørgensen S; Nielsen C; Jakobsen MA; Madsen RD; Jensen K; Krog GR; Rieneck K; Sprogøe U; Homburg KM; Grunnet N; Dziegiel MH
    Transfusion; 2012 Apr; 52(4):752-8. PubMed ID: 21995641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive fetal RHD genotyping from maternal plasma in an admixed Brazilian population.
    Schmidt LC; Cabral AC; Faria MA; Monken F; Tarazona-Santos E; Martins ML
    Genet Mol Res; 2014 Feb; 13(1):799-805. PubMed ID: 24615044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive fetal RHD genotyping to guide targeted anti-D prophylaxis-an external quality assessment workshop.
    Clausen FB; Barrett AN;
    Vox Sang; 2019 May; 114(4):386-393. PubMed ID: 30834546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RHD genotyping from maternal plasma: guidelines and technical challenges.
    Avent ND
    Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive Antenatal Screening for Fetal RHD in RhD Negative Women to Guide Targeted Anti-D Prophylaxis.
    Clausen FB; Rieneck K; Krog GR; Bundgaard BS; Dziegiel MH
    Methods Mol Biol; 2019; 1885():347-359. PubMed ID: 30506209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive fetal RhD genotyping from maternal blood.
    Kolialexi A; Tounta G; Mavrou A
    Expert Rev Mol Diagn; 2010 Apr; 10(3):285-96. PubMed ID: 20370586
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.